• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Organophosphate And Carbamate Poisoning - Pipeline Review, Q1 2011 - Product Image

Organophosphate And Carbamate Poisoning - Pipeline Review, Q1 2011

  • ID: 1524674
  • January 2011
  • 20 pages
  • Global Markets Direct

Organophosphate And Carbamate Poisoning - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Organophosphate And Carbamate Poisoning - Pipeline Review, Q1 2011', provides an overview of the Organophosphate And Carbamate Poisoning therapeutic pipeline. This report provides information on the therapeutic development for Organophosphate And Carbamate Poisoning, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Organophosphate And Carbamate Poisoning. 'Organophosphate And Carbamate Poisoning - Pipeline Review, Q1 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- A snapshot of the global therapeutic scenario for Organophosphate And Carbamate Poisoning.
- A review of the Organophosphate And Carbamate Poisoning products under development by companies and READ MORE >



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Organophosphate And Carbamate Poisoning Overview
Therapeutics Development
An Overview of Pipeline Products for Organophosphate And Carbamate Poisoning
Organophosphate And Carbamate Poisoning Therapeutics under Development by Companies
Organophosphate And Carbamate Poisoning Therapeutics under Investigation by Universities/Institutes
Companies Involved in Organophosphate And Carbamate Poisoning Therapeutics Development
MicroDose Technologies, Inc.
MicroDose Therapeutx, Inc.
Universities/Institutes Involved in Organophosphate And Carbamate Poisoning Therapeutics Development
Organophosphate And Carbamate Poisoning Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Organophosphate And Carbamate Poisoning - Featured News
Jan 04, 2011: Protalix To Present PRX-105 Data At BARDA Industry Day
Jun 08, 2010: Protalix Completes Phase I Clinical Trial For PRX-105
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Organophosphate And Carbamate Poisoning, 2011
Products under Development for Organophosphate And Carbamate Poisoning – Comparative Analysis, 2011
MicroDose Technologies, Inc., 2011
MicroDose Therapeutx, Inc., 2011
Assessment by Monotherapy Products, 2011
Assessment by Stage and Route of Administration, 2011
Assessment by Molecule Type, 2011

List of Figures
Number of Products under Development for Organophosphate And Carbamate Poisoning, 2011
Products under Development for Organophosphate And Carbamate Poisoning – Comparative Analysis, 2011
Products under Development by Companies, 2011
Products under Investigation by Universities/Institutes, 2011
Assessment by Monotherapy Products, 2011
Assessment by Route of Administration, 2011
Assessment by Stage and Route of Administration, 2011
Assessment by Molecule Type, 2011
Assessment by Stage and Molecule Type, 2011

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos